Market Update: Regeneron, UPS, and Zebra
Regeneron (REGN) has seemingly exited its bear phase, with shares rising 12% to over $650 after reporting a 0.8% revenue increase to $3.75 billion.
The company posted strong sales of Dupixent, at $4.9 billion, which offset weak sales from EYLEA. Notably, EYLEA HD sales grew by 42% to $663 million.
- Regeneron's revenue increase: 0.8% to $3.75 billion
- Dupixent sales: $4.9 billion
- EYLEA HD sales growth: 42% to $663 million
UPS, despite being down 25% in 2025, added 8.0% after posting non-GAAP EPS of $1.74 on revenue of $21.4 billion. The company announced a significant 48,000 job cut, with 34,000 in operational units and 14,000 at the management level.
Zebra (ZBRA) continued its downtrend, which began in August and accelerated in October, with the stock losing 11%.
No specific quote available in the given text.
Author's summary: Stocks show mixed results with Regeneron rising and Zebra falling.
More News
- A fencing club is born
- Yesilyurt: Lighting the way to sustainability
- Leftist virtue signalling is getting us nowhere
- From Reimagining Capitalism to Reweaving Ourselves: Leadership for a Sustainable and Caring Future in a World on Fire — Harvard ALI Social Impact Review
- US Ends Auto-Renewal of Work Permits, Indians Affected
- Tricks, treats, and total flops: How 2025 redefined, and recycled, horror - el Don News
- Lebanon and Syria October 2025: A Snapshot